Hims & Hers Health Faces Securities Fraud Class Action Lawsuit
Hims & Hers Health (HIMS) is facing a securities fraud class action lawsuit. The suit targets investors who purchased the company's stock within a specific period.

Hims & Hers Health, Inc. (HIMS) has been named in a securities fraud class action lawsuit. The litigation concerns investors who acquired the company's securities between August 4, 2025, and July 29, 2026.
The lawsuit alleges that the company made misleading statements to investors regarding its business operations and future prospects. Investors are claimed to have made their investment decisions based on this alleged false or incomplete information.
The legal proceedings require that investors who purchased HIMS securities during the specified class period must act by November 2, 2026, to be considered for lead plaintiff status. This deadline is critical for those seeking to actively participate in the lawsuit.
Hims & Hers Health will need to respond to these allegations within the legal framework. Further details regarding the specific claims and the company's defense are expected as the case progresses.